FOLD : Analysis & Opinions
November 30, 2016The launch of Amicus' Galafold drug to treat Fabry disease has been delayed until at least 2020.
November 8, 2016Amicus Therapeutics stock soared 21% even though the biotech company reported a 3Q loss.
May 18, 2016Below is a tool used by the Benzinga News Desk each trading day -- it's a look at everything happening in the market, in ...
April 12, 2016Shares of Amicus Therapeutics, Inc. (NASDAQ: FOLD) climbed 7 percent in the pre-market hours after a Wall Street analyst ...